Itolizumab Reduces Mortality in Patients Hospitalized with COVID
Clinical Trial Shows Itolizumab Reduces Mortality in Patients Hospitalized with COVID-19
Equillium shares topline results of patients treated with itolizumab in clinical trial conducted in India by partner Biocon
Biocon has received emergency use approval from Drugs Controller General of India for itolizumab in the treatment of CRS in COVID-19 patients with moderate to severe ARDS
Equillium planning global randomized controlled clinical trial of itolizumab in COVID-19 patients under a U.S. IND
globenewswire.com/news-release/2020/07/13/2060993/0/en/Clinical-Trial-Shows-Itolizumab-Reduces-Mortality-in-Patients-Hospitalized-with-COVID-19.html
Equillium shares topline results of patients treated with itolizumab in clinical trial conducted in India by partner Biocon
Biocon has received emergency use approval from Drugs Controller General of India for itolizumab in the treatment of CRS in COVID-19 patients with moderate to severe ARDS
Equillium planning global randomized controlled clinical trial of itolizumab in COVID-19 patients under a U.S. IND
globenewswire.com/news-release/2020/07/13/2060993/0/en/Clinical-Trial-Shows-Itolizumab-Reduces-Mortality-in-Patients-Hospitalized-with-COVID-19.html
إخلاء المسؤولية
لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.